RE:Quick questionjrsloan60 wrote: Why does it seem nobody wants the shares. Trades a hundred shares a day. Did our CEO get the market angry at him?
Money wants to see a proof of principle.
The Phase I/IIa clinical trial will provide safety/tolerability and preliminary efficacy data for the avenanthramide pill. Until you know it is safe/well tolerated and there are indications of preliminary efficacy it is very risky.
PGX has only been proven in a 10L pilot facility that you can't make any money from. By the end of the year it could be scaled 5X and 10X. The 5X facilty will allow small-scale commercial production and the 10X facility is the decision point for mass industrialization. A partnership could then be signed validating the technology.
Other programs are also before key proof of principle. Until there is a proof of principle we are early. It is not clear what we have or when. The diagnostic test while approved for adults has had a difficult launch. The coming pediatric data and deal will help clarify.